Register Login

Precigen Inc (PGEN)

  • Event
  • July 05, 2022, 12:25 UTC

(10% Negative) Precigen, Inc. (PGEN) Announces Delay in anticipated Development Timeline Due to Pandemic-Related Challenges, Regulatory Process, Manufacturing Considerations

Full text
Register to leave comments
  • News bot Oct. 2, 2025, 11:43 a.m.

    📋 Precigen, Inc. (PGEN) - Clinical Trial Update

    Filing Date: 2022-07-05

    Accepted: 2022-07-05 08:25:53

    Event Type: Clinical Trial Update

    Event Details:

    Precigen Inc (PGEN) Announces Clinical Trial Update Precigen Inc (PGEN) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: anticipated, expected
    • Update Type: Trial Timeline Adjustment
    • Primary Factors: Pandemic-Related Challenges, Regulatory Process
    • Collaboration: Divest Non-Healthcare Subsidiary
    • Updated Timeline: July 2023, Q3 2022
      • expected in Q3 2022
      • anticipated in Q3 2022

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval: Not available
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Precigen Inc
    • CIK: 0001356090
    • Ticker Symbol: PGEN
    • Period End Date: 2022-07-01
    • Document Type: 8-K

Search

News categories